213 related articles for article (PubMed ID: 21169446)
1. Different substrate recognition requirements for cleavage of synaptobrevin-2 by Clostridium baratii and Clostridium botulinum type F neurotoxins.
Kalb SR; Baudys J; Egan C; Smith TJ; Smith LA; Pirkle JL; Barr JR
Appl Environ Microbiol; 2011 Feb; 77(4):1301-8. PubMed ID: 21169446
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5.
Kalb SR; Baudys J; Webb RP; Wright P; Smith TJ; Smith LA; Fernández R; Raphael BH; Maslanka SE; Pirkle JL; Barr JR
FEBS Lett; 2012 Jan; 586(2):109-15. PubMed ID: 22172278
[TBL] [Abstract][Full Text] [Related]
3. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
Arndt JW; Chai Q; Christian T; Stevens RC
Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
[TBL] [Abstract][Full Text] [Related]
4. Exploration of endogenous substrate cleavage by various forms of botulinum neurotoxins.
Guo J; Wang J; Chan EW; Chen S
Toxicon; 2015 Jun; 100():42-5. PubMed ID: 25912942
[TBL] [Abstract][Full Text] [Related]
5. Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins.
Sikorra S; Henke T; Galli T; Binz T
J Biol Chem; 2008 Jul; 283(30):21145-52. PubMed ID: 18511418
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a novel botulinum neurotoxin.
Zhang S; Masuyer G; Zhang J; Shen Y; Lundin D; Henriksson L; Miyashita SI; Martínez-Carranza M; Dong M; Stenmark P
Nat Commun; 2017 Aug; 8():14130. PubMed ID: 28770820
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of substrate recognition and specificity of botulinum neurotoxin serotype F.
Chen S; Wan HY
Biochem J; 2011 Jan; 433(2):277-84. PubMed ID: 21029044
[TBL] [Abstract][Full Text] [Related]
8. Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin.
Yamasaki S; Baumeister A; Binz T; Blasi J; Link E; Cornille F; Roques B; Fykse EM; Südhof TC; Jahn R
J Biol Chem; 1994 Apr; 269(17):12764-72. PubMed ID: 8175689
[TBL] [Abstract][Full Text] [Related]
9. Botulinum neurotoxin detection and differentiation by mass spectrometry.
Barr JR; Moura H; Boyer AE; Woolfitt AR; Kalb SR; Pavlopoulos A; McWilliams LG; Schmidt JG; Martinez RA; Ashley DL
Emerg Infect Dis; 2005 Oct; 11(10):1578-83. PubMed ID: 16318699
[TBL] [Abstract][Full Text] [Related]
10. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity.
Schmidt JJ; Stafford RG
Biochemistry; 2005 Mar; 44(10):4067-73. PubMed ID: 15751983
[TBL] [Abstract][Full Text] [Related]
11. Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle Recycling.
Pellett S; Tepp WH; Scherf JM; Johnson EA
PLoS One; 2015; 10(7):e0133737. PubMed ID: 26207366
[TBL] [Abstract][Full Text] [Related]
12. Botulinum Neurotoxin F Subtypes Cleaving the VAMP-2 Q
Sikorra S; Skiba M; Dorner MB; Weisemann J; Weil M; Valdezate S; Davletov B; Rummel A; Dorner BG; Binz T
Toxins (Basel); 2018 Aug; 10(8):. PubMed ID: 30071628
[TBL] [Abstract][Full Text] [Related]
13. An innovative molecular detection tool for tracking and tracing Clostridium botulinum types A, B, E, F and other botulinum neurotoxin producing Clostridia based on the GeneDisc cycler.
Fach P; Fenicia L; Knutsson R; Wielinga PR; Anniballi F; Delibato E; Auricchio B; Woudstra C; Agren J; Segerman B; de Medici D; van Rotterdam BJ
Int J Food Microbiol; 2011 Mar; 145 Suppl 1():S145-51. PubMed ID: 20471128
[TBL] [Abstract][Full Text] [Related]
14. Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H.
Hackett G; Moore K; Burgin D; Hornby F; Gray B; Elliott M; Mir I; Beard M
Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29751611
[TBL] [Abstract][Full Text] [Related]
15. Sequence diversity of genes encoding botulinum neurotoxin type F.
Raphael BH; Choudoir MJ; Lúquez C; Fernández R; Maslanka SE
Appl Environ Microbiol; 2010 Jul; 76(14):4805-12. PubMed ID: 20511432
[TBL] [Abstract][Full Text] [Related]
16. Use of a recombinant fluorescent substrate with cleavage sites for all botulinum neurotoxins in high-throughput screening of natural product extracts for inhibitors of serotypes A, B, and E.
Hines HB; Kim AD; Stafford RG; Badie SS; Brueggeman EE; Newman DJ; Schmidt JJ
Appl Environ Microbiol; 2008 Feb; 74(3):653-9. PubMed ID: 18083881
[TBL] [Abstract][Full Text] [Related]
17. Development of real-time PCR tests for detecting botulinum neurotoxins A, B, E, F producing Clostridium botulinum, Clostridium baratii and Clostridium butyricum.
Fach P; Micheau P; Mazuet C; Perelle S; Popoff M
J Appl Microbiol; 2009 Aug; 107(2):465-73. PubMed ID: 19291235
[TBL] [Abstract][Full Text] [Related]
18. Mode of VAMP substrate recognition and inhibition of Clostridium botulinum neurotoxin F.
Agarwal R; Schmidt JJ; Stafford RG; Swaminathan S
Nat Struct Mol Biol; 2009 Jul; 16(7):789-94. PubMed ID: 19543288
[TBL] [Abstract][Full Text] [Related]
19. Three enzymatically active neurotoxins of Clostridium botulinum strain Af84: BoNT/A2, /F4, and /F5.
Kalb SR; Baudys J; Smith TJ; Smith LA; Barr JR
Anal Chem; 2014 Apr; 86(7):3254-62. PubMed ID: 24605815
[TBL] [Abstract][Full Text] [Related]
20. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
